[1]
Deeva , Y. and co-authors, et al. 2025. Clinical efficacy and safety of high-dose ambroxol in the form of oromucosal spray in postnasal drip syndrome: results of a multicenter study in Ukraine. Medicni perspektivi. 30, 2 (Jun. 2025), 61–77. DOI:https://doi.org/10.26641/2307-0404.2025.2.333376.